ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

8,059Medicare Part D Prescriptions Filled, Including Refills
$549K Total Retail Price of All Prescriptions
460 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LISINOPRIL 326 282
PRAVASTATIN SODIUM 273 214
ATORVASTATIN CALCIUM 255 227
FUROSEMIDE 244 195
LOSARTAN POTASSIUM 238 206
LEVOTHYROXINE SODIUM 214 171
METFORMIN HCL 195 157
AMLODIPINE BESYLATE 179 170
SIMVASTATIN 178 164
ZOLPIDEM TARTRATE 167 140
OMEPRAZOLE 155 138
SPIRIVA 134 109
METOPROLOL SUCCINATE 125 105
BENICAR 124 124
CITALOPRAM HBR 115 113
ATENOLOL 111 87
HYDROCHLOROTHIAZIDE 109 109
ADVAIR DISKUS 104 80
AMLODIPINE BESYLATE-BENAZEPRIL 100 96
BYSTOLIC 97 94
CRESTOR 95 76
DONEPEZIL HCL 92 92
METOPROLOL TARTRATE 92 92
WARFARIN SODIUM 92 89
TRAMADOL HCL 92 81
LOVASTATIN 89 89
GABAPENTIN 83 68
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 51
SYMBICORT 81 65
GLYBURIDE-METFORMIN HCL 77 57 R
AZITHROMYCIN 76 60
DILTIAZEM 24HR ER 76 71
JANUVIA 70 57
PANTOPRAZOLE SODIUM 65 65
GLIMEPIRIDE 62 58
NEXIUM 60 59
DIOVAN 60 35
POTASSIUM CHLORIDE 59 58
PREDNISONE 57 44
ALLOPURINOL 55 50
HYDROCODONE-ACETAMINOPHEN 54 36 S3
PROAIR HFA 54 31
CYMBALTA 51 42
ESCITALOPRAM OXALATE 51 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.